CXCL12 in Pancreatic Cancer: Its Function and Potential as a Therapeutic Drug Target.
Saved in:
| Title: | CXCL12 in Pancreatic Cancer: Its Function and Potential as a Therapeutic Drug Target. |
|---|---|
| Authors: | Malik S; Kura Oncology, Inc., San Diego, CA 92130, USA., Westcott JM; Division of Surgical Oncology, Department of Surgery, and Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA., Brekken RA; Division of Surgical Oncology, Department of Surgery, and Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA., Burrows FJ; Kura Oncology, Inc., San Diego, CA 92130, USA. |
| Source: | Cancers [Cancers (Basel)] 2021 Dec 24; Vol. 14 (1). Date of Electronic Publication: 2021 Dec 24. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 35008248 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: CXCL12 in Pancreatic Cancer: Its Function and Potential as a Therapeutic Drug Target. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Malik+S%22">Malik S</searchLink>; Kura Oncology, Inc., San Diego, CA 92130, USA.<br /><searchLink fieldCode="AU" term="%22Westcott+JM%22">Westcott JM</searchLink>; Division of Surgical Oncology, Department of Surgery, and Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.<br /><searchLink fieldCode="AU" term="%22Brekken+RA%22">Brekken RA</searchLink>; Division of Surgical Oncology, Department of Surgery, and Hamon Center for Therapeutic Oncology Research, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.<br /><searchLink fieldCode="AU" term="%22Burrows+FJ%22">Burrows FJ</searchLink>; Kura Oncology, Inc., San Diego, CA 92130, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101526829%22">Cancers</searchLink> [Cancers (Basel)] 2021 Dec 24; Vol. 14 (1). <i>Date of Electronic Publication: </i>2021 Dec 24. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22MDPI%22">MDPI </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101526829 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2072-6694 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220726694%22">20726694 </searchLink><i>NLM ISO Abbreviation: </i>Cancers (Basel) <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35008248 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3390/cancers14010086 Languages: – Code: eng Text: English Titles: – TitleFull: CXCL12 in Pancreatic Cancer: Its Function and Potential as a Therapeutic Drug Target. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Malik S – PersonEntity: Name: NameFull: Westcott JM – PersonEntity: Name: NameFull: Brekken RA – PersonEntity: Name: NameFull: Burrows FJ IsPartOfRelationships: – BibEntity: Dates: – D: 24 M: 12 Text: 2021 Dec 24 Type: published Y: 2021 Identifiers: – Type: issn-print Value: 2072-6694 Numbering: – Type: volume Value: 14 – Type: issue Value: 1 Titles: – TitleFull: Cancers Type: main |
| ResultId | 1 |
